Potential medicinal plants for CNS disorders: an overview

  title={Potential medicinal plants for CNS disorders: an overview},
  author={Vikas Kumar},
  journal={Phytotherapy Research},
  • Vikas Kumar
  • Published 1 December 2006
  • Medicine
  • Phytotherapy Research
Although very few drugs are currently approved by regulatory authorities for treating multi‐factorial ailments and disorders of cognition such as Alzheimer's disease, certain plant‐derived agents, including, for example, galantamine and rivastigmine (a semi‐synthetic derivative of physostigmine) are finding an application in modern medicine. However, in Ayurveda, the Indian traditional system of medicine which is more than 5000 years old, selected plants have long been classified as ‘medhya… 

Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease

The primitive remedies as well as the development of herbal remedies for AD management are provided, which may be useful in the discovery and advancement of drugs, thus extending new leads for neurodegenerative diseases such as AD.

Ethnopharmacological review of native traditional medicinal plants for brain disorders

Well known medicinal plants of Indian origin, including Withania somnifera, Bacopa monniera, Centella asiatica, Convolvulus pluricaulis, Emblica officinalis and Ocimum sanctum reputed for their effectiveness in CNS disorders are discussed.

Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs

The importance of phytochemicals on neuroprotective function and other related disorders, in particular their mechanism of action and therapeutic potential are highlighted.

Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview

People who eat more vegetables and fruits may be less risk of developing certain diseases caused by neurological dysfunction, and indication recommends that chronic herbs used to cure neurological symptoms are recommended.


Traditional herbal medicines, either directly as supplements or indirectly in the form of food, improve brain functions including learning, memory and attention and quality of life with either no or limited side effects.

Ayurvedic medicinal plants for Alzheimer's disease: a review

This review gathers research on various medicinal plants that have shown promise in reversing the Alzheimer's disease pathology and summarizes information concerning the phytochemistry, biological, and cellular activities and clinical applications of these various plants in order to provide sufficient baseline information that could be used in drug discovery campaigns and development process.


It was observed in this review that a number of herbal medicines used in ayurvedic practices contain multiple compounds and phytochemicals that may have a neuroprotective effect which may prove beneficial in different neuropsychiatric and neurodegenerative disorders.

Neuroprotective potential of phytochemicals

It was observed in the review that a number of herbal medicines used in Ayurvedic practices as well Chinese medicines contain multiple compounds and phytochemicals that may have a neuroprotective effect which may prove beneficial in different neuropsychiatric and neurodegenerative disorders.



A review of herbal medicines for psychiatric disorders.

Evidence of the efficacy of herbal preparations in treating psychiatric conditions is growing, but translating the results of efficacy studies into effective treatments for patients is hampered by the chemical complexity of the products, the lack of standardization of commonly available preparations, and the paucity of well-controlled studies.

Herbal remedies in the United States: potential adverse interactions with anticancer agents.

It is suggested that health care professionals and consumers should be aware of the potential for adverse interactions with these herbs, question their patients on their use of them, and urge patients to avoid herbs that could confound their cancer care.

Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability

There is a need for longer-term controlled studies with some of these compounds (particularly valerian) and aromatherapy constitutes a tantalising possibility, but how practical a form of treatment this may be remains to be determined.

Adverse-Effect Profile of Kava

The data support the safety of kava in treating anxiety at 280 mg kava lactones/day for 4 weeks, including findings from a study of its use in generalized anxiety disorder.

Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.

Results suggest that some of the constituents of the non-flavone fraction of EGb 761 possess neuroprotective and anti-apoptotic capacity, and that bilobalide is the most potent one.

Kava extracts: safety and risks including rare hepatotoxicity.

A critical analysis of the suspected cases in Germany reveals that only in 1 single patient a very probable causal relationship could be established between kava treatment and the development of toxic liver disease due to a positive result of an unscheduled reexposure test, whereas in another patient there might be a possible association.

Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.

  • V. Schulz
  • Psychology, Medicine
    Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2003
Given the limited therapeutic options for DAT, treatment with EGb still appears to be the method of choice compared to the ChE inhibitors, but the relatively small differences are called into question by the occurrence of drug-specific side effects with the Ch E inhibitors.

A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts.

Some of the controversial evidence derived from clinical and experimental studies suggesting that H. perforatum exerts antidepressant-like actions are reviewed, and some of its side effects, such as nausea, rash, fatigue, restlessness, photosensitivity, acute neuropathy, and even episodes of mania and serotonergic syndrome when administered simultaneously with other antidepressant drugs are reviewed.